Orchestra BioMed (OBIO)
Develops partnership-enabled device therapies for hypertension and artery disease.
$5.94
vs last close−0.28 (−4.50%)
Something off on this page? Send us feedback.
Next report
Nov 9, 26
estimated · in 47 days
EPS estimate
−$0.40
Revenue estimate
$128.0K
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Mar '25Apr '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported−$0.37−$0.43−$0.50−$0.40$0.12−$0.33−$0.38Pending
Estimate−$0.43−$0.43−$0.51−$0.38−$0.38−$0.40−$0.39−$0.40
Surprise+14.0%0.0%+2.0%−5.3%+131.6%+17.5%+3.1%—
RevenueReportedEstimate
Mar '25Apr '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported$253.0K$253.0K$836.0K$861.0K$30.9M$110.0K$88.0KPending
Estimate—$522.3K$778.8K$741.4K$931.0K$918.7K$137.7K$128.0K
Surprise—−51.6%+7.3%+16.1%+3,220.8%−88.0%−36.1%—
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Sep 2030 | $0.00 | — | — |
| Jun 2030 | $0.00 | — | — |
| Mar 2030 | $0.00 | — | — |
| Dec 2029 | −$0.12 | — | — |
| Sep 2029 | −$0.14 | — | — |
| Jun 2029 | −$0.15 | — | — |
| Mar 2029 | −$0.16 | — | — |
| Dec 2028 | −$0.24 | — | — |
| Sep 2028 | −$0.26 | — | — |
| Jun 2028 | −$0.27 | — | — |
| Mar 2028 | −$0.31 | — | — |
| Dec 2027 | −$0.34 | — | — |
| Sep 2027 | −$0.37 | — | — |
| Jun 2027 | −$0.37 | — | — |
| Mar 2027 | −$0.38 | — | — |
| Dec 2026 | −$0.41 | — | — |
| Nov 2026 | −$0.40 | — | — |
| Aug 2026 | −$0.39 | −$0.38 | +3.1% |
| May 2026 | −$0.40 | −$0.33 | +17.5% |
| Mar 2026 | −$0.38 | $0.12 | +131.6% |
| Nov 2025 | −$0.38 | −$0.40 | −5.3% |
| Aug 2025 | |||
| Apr 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Jan 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| Jun 2022 | |||
| Mar 2022 | |||
| Dec 2021 | |||
| Sep 2021 | |||
| Jun 2021 | |||
| Mar 2021 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Sep 2030 | $0.00 | — | — | $22.5M | — | — | — |
| Jun 2030 | $0.00 | — | — | $20.5M | — | — | — |
| Mar 2030 | $0.00 | — | — | $16.6M | — | — | — |
| Dec 2029 | −$0.12 | — | — | $12.0M | — | — | — |
| Sep 2029 | −$0.14 | — | — | $9.3M | — | — | — |
| Jun 2029 | −$0.15 | — | — | $7.4M | — | — | — |
| Mar 2029 | −$0.16 | — | — | $5.1M | — | — | — |
| Dec 2028 | −$0.24 | — | — | $3.3M | — | — | — |
| Sep 2028 | −$0.26 | — | — | $1.8M | — | — | — |
| Jun 2028 | −$0.27 | — | — | $545.1K | — | — | — |
| Mar 2028 | −$0.31 | — | — | $90.0K | — | — | — |
| Dec 2027 | −$0.34 | — | — | $201.0K | — | — | — |
| Sep 2027 | −$0.37 | — | — | $140.4K | — | — | — |
| Jun 2027 | −$0.37 | — | — | $112.0K | — | — | — |
| Mar 2027 | −$0.38 | — | — | $96.6K | — | — | — |
| Dec 2026 | −$0.41 | — | — | $133.0K | — | — | — |
| Nov 9, 2026 | −$0.40 | — | — | $128.0K | — | — | — |
| Aug 10, 2026 | −$0.39 | −$0.38 | +3.1% | $137.7K | $88.0K | −36.1% | −1.4% |
| May 12, 2026 | −$0.40 | −$0.33 | +17.5% | $918.7K | $110.0K | −88.0% | +3.8% |
| Mar 12, 2026 | −$0.38 | $0.12 | +131.6% | $931.0K | $30.9M | +3,220.8% | −4.8% |
| Nov 10, 2025 | −$0.38 | −$0.40 | −5.3% | $741.4K | $861.0K | +16.1% | −0.8% |
| Aug 12, 2025 | |||||||
| Apr 2, 2025 | |||||||
| Mar 26, 2025 | |||||||
| Nov 12, 2024 | |||||||
| Aug 12, 2024 | |||||||
| May 13, 2024 | |||||||
| Mar 27, 2024 | |||||||
| Nov 13, 2023 | |||||||
| Aug 10, 2023 | |||||||
| May 12, 2023 | |||||||
| Jan 25, 2023 | |||||||
| Nov 14, 2022 | |||||||
| Aug 15, 2022 | |||||||
| Jun 30, 2022 | |||||||
| Mar 31, 2022 | |||||||
| Dec 31, 2021 | |||||||
| Sep 30, 2021 | |||||||
| Jun 30, 2021 | |||||||
| Mar 31, 2021 |